The Authority of Research and Development wishes to congratulate the grantees of research awards:Prof. Victor Kagalovski, Dr Yoram Shotland and Dr. Michal Shachar Goldenberg
The Authority of Research and Development wishes to congratulate the grantees of research awards:
Prof. Victor Kagalovski from the Physics Unit for being granted the BSF research fund for the second time.
Dr Yoram Shotland from the Department of Chemical Engineering for being granted the ISF fund together with the
Prof. Victor Kagalovski from the Physics unit at SCE- Shamoon academic
The bi-national science foundation promotes scientific cooperation between
Dr Yoram Shotland, a senior lecturer from the Department of Chemical engineering at SCE- Shamoon Academic College of Engineering, was given a research grant by the prestigious ISF foundation, together with two researchers from the
The grant was given to researchers Prof. Aharon Kaplan and Prof. Itzhak Ohad from the
The researchers intend to decode the algae's genome in order to investigate the inter-cellular mechanisms enabling such fast photosynthesis rates in laboratory conditions on one hand and a high resistance to aridity (with a reduction in the photosynthesis rate) on the other hand.
Dr Michal Shachar Goldenberg from the Department of Chemical Engineering at SCE-Shamoon College of Engineering was recently given a prestigious grant of 40,000 Euro for one year from the GIF program for young scientists on the subject of in vitro cultivation of immature ovary follicles and the generation of artificial ovary tissue. Dr Goldenberg is testing a strategy from the field of tissue engineering for this purpose in cooperation with the "fertility and stem cell laboratory" at the
The research also focuses on the development of assigned systems for the external cultivation of follicles, incorporating the immersion of mechanical forces similar to those applied on the follicle in its natural environment together with already existing systems to maintain a monitored and dynamic cultivation environment. This work may answer the need of cancer patients to maintain their fertility before undergoing chemotherapeutic treatments which often damage it. The options for fertility maintenance are today still scarce and not suitable for every patient and may, in some cases, hold the danger of returning cancerous cells into the body with the frozen ovary tissue. The technology aimed at in Dr Goldenberg's work will address a wider range of patients and will not endanger them with the possibility of reoccurring cancer.






Back